Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Leadership, Longevity, and Leaning In: An Interview With Mary Jo (Joey) Bulfin.

Prestia AS.

J Nurs Adm. 2018 Jun;48(6):298-299. doi: 10.1097/NNA.0000000000000617.

PMID:
29794593
2.

Win-win leadership practicums.

Sherman RO, Prestia AS.

Nurs Manage. 2018 Apr;49(4):7-8. doi: 10.1097/01.NUMA.0000529933.83408.06. No abstract available.

PMID:
29596136
3.

Self-Care for Nurse Leaders in Acute Care Environment Reduces Perceived Stress: A Mixed-Methods Pilot Study Merits Further Investigation.

Dyess SML, Prestia AS, Marquit DE, Newman D.

J Holist Nurs. 2018 Mar;36(1):79-90. doi: 10.1177/0898010116685655. Epub 2017 Jan 6.

PMID:
29172903
4.

The art of leadership diplomacy.

Prestia AS.

Nurs Manage. 2017 Apr;48(4):52-55. doi: 10.1097/01.NUMA.0000514068.76314.4d. No abstract available.

PMID:
28353481
5.

Chief Nursing Officers' Experiences With Moral Distress.

Prestia AS, Sherman RO, Demezier C.

J Nurs Adm. 2017 Feb;47(2):101-107. doi: 10.1097/NNA.0000000000000447.

PMID:
28067680
6.

Chief Nursing Officer Sustainment: A Phenomenological Inquiry.

Prestia AS.

J Nurs Adm. 2015 Nov;45(11):575-81. doi: 10.1097/NNA.0000000000000266.

PMID:
26492150
7.

Support for caring and resiliency among successful nurse leaders.

Dyess SM, Prestia AS, Smith MC.

Nurs Adm Q. 2015 Apr-Jun;39(2):104-16. doi: 10.1097/NAQ.0000000000000101.

PMID:
25714947
8.

Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics.

Prestia A, Caroli A, Wade SK, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB.

Alzheimers Dement. 2015 Oct;11(10):1191-201. doi: 10.1016/j.jalz.2014.12.001. Epub 2015 Jan 31.

PMID:
25646957
9.

Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression.

Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen C, Wall AE, Carter SF, Schöll M, Choo IH, Grimmer T, Redolfi A, Nordberg A, Scheltens P, Drzezga A, Frisoni GB; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2015 Feb 3;84(5):508-15. doi: 10.1212/WNL.0000000000001209. Epub 2015 Jan 7.

10.

Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer's disease.

Babiloni C, Del Percio C, Boccardi M, Lizio R, Lopez S, Carducci F, Marzano N, Soricelli A, Ferri R, Triggiani AI, Prestia A, Salinari S, Rasser PE, Basar E, Famà F, Nobili F, Yener G, Emek-Savaş DD, Gesualdo L, Mundi C, Thompson PM, Rossini PM, Frisoni GB.

Neurobiol Aging. 2015 Feb;36(2):556-70. doi: 10.1016/j.neurobiolaging.2014.09.011. Epub 2014 Sep 21.

11.

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.

Caroli A, Prestia A, Wade S, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Reiman EM, Jagust WJ, Frisoni GB; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2015 Apr-Jun;29(2):101-9. doi: 10.1097/WAD.0000000000000071.

12.

A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.

Della Rosa PA, Cerami C, Gallivanone F, Prestia A, Caroli A, Castiglioni I, Gilardi MC, Frisoni G, Friston K, Ashburner J, Perani D; EADC-PET Consortium.

Neuroinformatics. 2014 Oct;12(4):575-93. doi: 10.1007/s12021-014-9235-4.

PMID:
24952892
13.

Planting seeds of succession.

Prestia AS, Dyess SM, Sherman RO.

Nurs Manage. 2014 Mar;45(3):30-7. doi: 10.1097/01.NUMA.0000443941.68503.09. No abstract available.

PMID:
24569680
14.

Hippocampal and amygdalar local structural differences in elderly patients with schizophrenia.

Prestia A, Cavedo E, Boccardi M, Muscio C, Adorni A, Geroldi C, Bonetti M, Thompson PM, Frisoni GB.

Am J Geriatr Psychiatry. 2015 Jan;23(1):47-58. doi: 10.1016/j.jagp.2014.01.006. Epub 2014 Jan 22.

15.

Increase of theta frequency is associated with reduction in regional cerebral blood flow only in subjects with mild cognitive impairment with higher upper alpha/low alpha EEG frequency power ratio.

Moretti DV, Prestia A, Binetti G, Zanetti O, Frisoni GB.

Front Behav Neurosci. 2013 Dec 5;7:188. doi: 10.3389/fnbeh.2013.00188. eCollection 2013.

16.

The in vivo topography of cortical changes in healthy aging and prodromal Alzheimer's disease.

Prestia A, Baglieri A, Pievani M, Bonetti M, Rasser PE, Thompson PM, Marino S, Bramanti P, Frisoni GB.

Suppl Clin Neurophysiol. 2013;62:67-80.

PMID:
24053032
17.

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease.

Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall AE, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB.

Neurology. 2013 Mar 12;80(11):1048-56. doi: 10.1212/WNL.0b013e3182872830. Epub 2013 Feb 6.

PMID:
23390179
18.

Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series.

Prestia A, Caroli A, Herholz K, Reiman E, Chen K, Jagust WJ, Frisoni GB; Translational Outpatient Memory Clinic Working Group; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2013 Nov;9(6):677-86. doi: 10.1016/j.jalz.2012.09.016. Epub 2013 Jan 30.

19.

Succession planning for the future through an academic-practice partnership: a nursing administration master's program for emerging nurse leaders.

Sherman R, Dyess S, Hannah E, Prestia A.

Nurs Adm Q. 2013 Jan-Mar;37(1):18-27. doi: 10.1097/NAQ.0b013e31827514ba.

PMID:
23222750
20.

Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia.

Albertini V, Benussi L, Paterlini A, Glionna M, Prestia A, Bocchio-Chiavetto L, Amicucci G, Galluzzi S, Adorni A, Geroldi C, Binetti G, Frisoni GB, Ghidoni R.

Electrophoresis. 2012 Dec;33(24):3738-44. doi: 10.1002/elps.201200307. Epub 2012 Nov 26.

PMID:
23161113
21.

Specific EEG changes associated with atrophy of hippocampus in subjects with mild cognitive impairment and Alzheimer's disease.

Moretti DV, Prestia A, Fracassi C, Binetti G, Zanetti O, Frisoni GB.

Int J Alzheimers Dis. 2012;2012:253153. doi: 10.1155/2012/253153. Epub 2012 Feb 12.

22.

Maximizing caring relationships between nursing assistants and patients: care partners.

Prestia A, Dyess S.

J Nurs Adm. 2012 Mar;42(3):144-7. doi: 10.1097/NNA.0b013e3182484efd.

PMID:
22361871
23.

Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison.

Caroli A, Prestia A, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Nobili F, Reiman EM, Jagust WJ, Frisoni GB; EADC-PET Consortium, NEST-DD, and Alzheimer's Disease Neuroimaging Initiative.

J Nucl Med. 2012 Apr;53(4):592-600. doi: 10.2967/jnumed.111.094946. Epub 2012 Feb 17.

24.

Volumetric differences in mapped hippocampal regions correlate with increase of high alpha rhythm in Alzheimer's disease.

Moretti DV, Prestia A, Fracassi C, Geroldi C, Binetti G, Rossini PM, Zanetti O, Frisoni GB.

Int J Alzheimers Dis. 2011;2011:208218. doi: 10.4061/2011/208218. Epub 2011 Jun 14.

25.

Hippocampal and amygdalar volume changes in elderly patients with Alzheimer's disease and schizophrenia.

Prestia A, Boccardi M, Galluzzi S, Cavedo E, Adorni A, Soricelli A, Bonetti M, Geroldi C, Giannakopoulos P, Thompson P, Frisoni G.

Psychiatry Res. 2011 May 31;192(2):77-83. doi: 10.1016/j.pscychresns.2010.12.015. Epub 2011 Apr 1.

PMID:
21458960
26.

Cortical changes in incipient Alzheimer's disease.

Prestia A, Drago V, Rasser PE, Bonetti M, Thompson PM, Frisoni GB.

J Alzheimers Dis. 2010;22(4):1339-49. doi: 10.3233/JAD-2010-101191.

PMID:
20930288
27.

Alzheimer's CSF markers in older schizophrenia patients.

Frisoni GB, Prestia A, Geroldi C, Adorni A, Ghidoni R, Amicucci G, Bonetti M, Soricelli A, Rasser PE, Thompson PM, Giannakopoulos P.

Int J Geriatr Psychiatry. 2011 Jun;26(6):640-8. doi: 10.1002/gps.2575. Epub 2010 Sep 27.

PMID:
20872913
28.

Markers of Alzheimer's disease in a population attending a memory clinic.

Frisoni GB, Prestia A, Zanetti O, Galluzzi S, Romano M, Cotelli M, Gennarelli M, Binetti G, Bocchio L, Paghera B, Amicucci G, Bonetti M, Benussi L, Ghidoni R, Geroldi C.

Alzheimers Dement. 2009 Jul;5(4):307-17. doi: 10.1016/j.jalz.2009.04.1235.

PMID:
19560101
29.

In vivo neuropathology of cortical changes in elderly persons with schizophrenia.

Frisoni GB, Prestia A, Adorni A, Rasser PE, Cotelli M, Soricelli A, Bonetti M, Geroldi C, Giannakopoulos P, Thompson PM.

Biol Psychiatry. 2009 Sep 15;66(6):578-85. doi: 10.1016/j.biopsych.2009.02.011. Epub 2009 May 1.

PMID:
19409532
30.

In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer's disease.

Frisoni GB, Prestia A, Rasser PE, Bonetti M, Thompson PM.

J Neurol. 2009 Jun;256(6):916-24. doi: 10.1007/s00415-009-5040-7. Epub 2009 Feb 28.

PMID:
19252794
31.

Resting EEG sources correlate with attentional span in mild cognitive impairment and Alzheimer's disease.

Babiloni C, Cassetta E, Binetti G, Tombini M, Del Percio C, Ferreri F, Ferri R, Frisoni G, Lanuzza B, Nobili F, Parisi L, Rodriguez G, Frigerio L, Gurzì M, Prestia A, Vernieri F, Eusebi F, Rossini PM.

Eur J Neurosci. 2007 Jun;25(12):3742-57.

PMID:
17610594
32.

Validation study of the three-objects-three-places test: a screening test for Alzheimer's disease.

Prestia A, Rossi R, Geroldi C, Galluzzi S, Ettori M, Alaimo G, Frisoni GB.

Exp Aging Res. 2006 Oct-Dec;32(4):395-410.

PMID:
16982570
33.

Methotrexate and the photodermatitis reactivation reaction: a case report and review of the literature.

Khan AJ, Marghoob AA, Prestia AE, Spector IJ.

Cutis. 2000 Nov;66(5):379-82.

PMID:
11107525
34.

Topical benzoyl peroxide for the treatment of tinea versicolor.

Prestia AE.

J Am Acad Dermatol. 1983 Aug;9(2):277-8. No abstract available.

PMID:
6886121
35.

Chancres in syphilis.

Prestia AE.

Arch Dermatol. 1980 Jan;116(1):20-1. No abstract available.

PMID:
7352761
36.

Failure to induce immune tolerance to nitrogen mustard. Intravenous administration preceding topical use in patients with proriasis.

Baer RL, Michaelides P, Prestia AE.

J Invest Dermatol. 1972 Jan;58(1):1-4. No abstract available.

37.

Photo-urticaria.

Hyman A, Prestia A.

Arch Dermatol. 1971 Oct;104(4):441-2. No abstract available.

PMID:
5114424
38.

Scarlatiniform eruption in viral hepatitis.

Prestia AE, Lynfield YL.

Arch Dermatol. 1970 Mar;101(3):352-5. No abstract available.

PMID:
5414893
39.

Alcoholic urticaria (? cholinergic) and delayed pressure urticaria.

Biro L, Pecache JC, Lynfield YL, Prestia AE.

Arch Dermatol. 1969 Nov;100(5):644-6. No abstract available.

PMID:
5350423
40.

Systemic lupus erythematosus with nodular lesions.

Lynfield YL, Prestia AE.

Arch Dermatol. 1969 Nov;100(5):642-3. No abstract available.

PMID:
5350421
41.

[Endocrine changes due to extracellular tumors].

Molocznik I, Pardal C, Amezua L, Dickmann GH, Prestia A, Martínez Montes M, Perez Lloret A.

Prensa Med Argent. 1967 Dec;54(39):2147-52. Spanish. No abstract available.

PMID:
5620681

Supplemental Content

Loading ...
Support Center